Asia Medical & Agricultural Laboratory & Research Center PCL
SET:AMARC
Cash Flow Statement
Cash Flow Statement
Asia Medical & Agricultural Laboratory & Research Center PCL
| Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Net Income |
31
|
15
|
15
|
6
|
7
|
10
|
15
|
20
|
30
|
40
|
57
|
127
|
153
|
159
|
|
| Depreciation & Amortization |
39
|
34
|
42
|
35
|
36
|
37
|
38
|
39
|
40
|
40
|
41
|
41
|
41
|
42
|
|
| Other Non-Cash Items |
18
|
13
|
15
|
9
|
8
|
6
|
4
|
4
|
3
|
0
|
1
|
(0)
|
(1)
|
1
|
|
| Cash Taxes Paid |
3
|
2
|
3
|
2
|
2
|
2
|
2
|
(1)
|
(0)
|
(0)
|
0
|
4
|
3
|
0
|
|
| Cash Interest Paid |
8
|
6
|
7
|
4
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
|
| Change in Working Capital |
(17)
|
(8)
|
(12)
|
8
|
(2)
|
(8)
|
(0)
|
(8)
|
(8)
|
(1)
|
(10)
|
3
|
12
|
7
|
|
| Cash from Operating Activities |
72
N/A
|
54
-26%
|
61
+14%
|
58
-6%
|
48
-16%
|
45
-6%
|
57
+25%
|
56
-2%
|
66
+18%
|
80
+21%
|
89
+12%
|
171
+92%
|
206
+20%
|
208
+1%
|
|
| Investing Cash Flow | |||||||||||||||
| Capital Expenditures |
(30)
|
(22)
|
(34)
|
(48)
|
(52)
|
(59)
|
(50)
|
(33)
|
(26)
|
(24)
|
(30)
|
(27)
|
(48)
|
(50)
|
|
| Other Items |
0
|
(180)
|
(149)
|
(129)
|
(119)
|
81
|
52
|
31
|
27
|
8
|
7
|
(42)
|
(48)
|
(48)
|
|
| Cash from Investing Activities |
(30)
N/A
|
(202)
-574%
|
(183)
+9%
|
(176)
+4%
|
(171)
+3%
|
22
N/A
|
2
-90%
|
(1)
N/A
|
2
N/A
|
(16)
N/A
|
(22)
-41%
|
(70)
-215%
|
(96)
-37%
|
(98)
-2%
|
|
| Financing Cash Flow | |||||||||||||||
| Net Issuance of Common Stock |
0
|
348
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(17)
|
(135)
|
(147)
|
(164)
|
(166)
|
(37)
|
(34)
|
(35)
|
(33)
|
(31)
|
(29)
|
(21)
|
(24)
|
(22)
|
|
| Other |
(23)
|
(21)
|
(22)
|
(46)
|
(45)
|
(45)
|
(45)
|
(18)
|
(27)
|
(35)
|
(35)
|
(27)
|
(60)
|
(72)
|
|
| Cash from Financing Activities |
(40)
N/A
|
192
N/A
|
179
-7%
|
138
-23%
|
137
-1%
|
(82)
N/A
|
(79)
+4%
|
(53)
+32%
|
(60)
-12%
|
(66)
-11%
|
(64)
+4%
|
(48)
+24%
|
(84)
-75%
|
(94)
-12%
|
|
| Change in Cash | |||||||||||||||
| Net Change in Cash |
2
N/A
|
44
+2 055%
|
58
+30%
|
19
-67%
|
15
-23%
|
(14)
N/A
|
(20)
-36%
|
1
N/A
|
7
+631%
|
(3)
N/A
|
3
N/A
|
53
+1 471%
|
25
-52%
|
16
-39%
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
42
N/A
|
32
-25%
|
27
-14%
|
10
-64%
|
(4)
N/A
|
(13)
-265%
|
7
N/A
|
22
+217%
|
40
+77%
|
56
+41%
|
59
+6%
|
144
+142%
|
157
+9%
|
157
+0%
|
|